Malaysia’s Drug Control Authority (DCA) has granted conditional approval for a second source of the Covid-19 vaccine co-developed by AstraZeneca and the University of Oxford, bringing the vaccine a step closer towards its use in the country’s ongoing vaccination campaign.

In a statement today, Health Ministry director-general Dr Noor Hisham Abdullah said the DCA agreed to register AstraZeneca’s contract manufacturer SK Bioscience Co Ltd in South Korea, during a meeting today...